1. Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). Issue 5 (9th February 2022) Authors: Lavynenko, Olga; Abdul‐Ghani, Muhammad; Alatrach, Mariam; Puckett, Curtiss; Adams, John; Abdelgani, Siham; Alkhouri, Naim; Triplitt, Curtis; Clarke, Geoffrey D.; Vasquez, Juan A.; Li, Jinqi; Cersosimo, Eugenio; Gastaldelli, Amalia; DeFronzo, Ralph A. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 5(2022) Page Start: 899 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗